Hiroshima G7 Global Health Task Force


In 2023, Japan will host the G7 Summit in Hiroshima, the “City of Peace.” Ahead of the Summit, JCIE has established the Hiroshima G7 Global Health Task Force under the Executive Committee on Global Health and Human Security (Chairman: Keizo Takemi, Member of the House of Councillors; Executive Director: Akio Okawara, President and CEO, JCIE) to make recommendations to the Japanese government on the G7 agenda and concrete measures to be promoted for global health in the context of the rapidly changing global health architecture.

Research teams will be created to examine the three major themes outlined below. The Task Force will then organize international dialogues that engage representatives from diverse sectors across non-G7 countries and will actively take part in global discussions that are currently underway. By doing so, it will seek to reaffirm Japan’s position in the ever-changing international community, identify areas in which Japan should lead as the 2023 G7 chair, and explore specific measures to pursue.

1.  100 Days Mission and Access & Delivery (100 Days Mission PLUS)

2.  Resilient, Equitable, and Sustainable UHC

3. Global Health Architecture Development

The 2023 G7 Summit will be held on May 19–21 in Hiroshima, Japan. The invasion of Ukraine by Russia, a permanent member of the UN Security Council, has raised many issues for the current international framework, and Japan must rebuild its diplomatic power and consider how it can contribute to the realization of a peaceful and stable international community. Global health is an important theme that could become a key pillar as Japan reestablishes its diplomatic capacity.

In the field of global health, the global spread of the COVID-19 pandemic has made the link between health and society, the economy, and security even clearer than before, and beyond just the health sector, it has indicated the need for commitment and leadership at the head-of-state level. In addition, it has spurred an active discussion in the international community on how to enhance the response for and preparedness to health crises, including pandemics.

On May 24, 2022, Japan announced its Global Health Strategy. The strategy includes the following as its major goals: (1) to contribute to developing a resilient global health architecture for prevention, preparedness, and response (PPR) to public health crises, including pandemics; and (2) to realize human security by accelerating the efforts to achieve more resilient, equitable, and sustainable Universal Health Coverage (UHC), a necessary goal in the new era post-COVID. A summary of the Global Health Strategy strategy can be found here.

The “G7 Ise-Shima Vision for Global Health,” which was approved during the 2016 summit  hosted by Japan, identified achieving UHC and responding to health crises as the “two wheels of the cart.” This policy framework has become even more relevant now in light of the COVID-19 experience. Moreover, given Japan’s advocacy for sustainable UHC and its role in placing population aging on the G20 agenda for the first time at the 2019 G20 Osaka Summit, supporting preparedness that reflects the world’s demographic shifts and changes in epidemiological structures is another issue that Japan should pursue.

This Task Force is being convened by JCIE’s Executive Committee on Global Health and Human Securitya unique public-private platform established in 2007 that facilitates the Japanese government’s policymaking on global health and public-private collaboration in that field. The committee similarly convened a working group to make recommendations in the lead-up to the 2016 G7 Summit.  


HIDEAKI SHIROYAMA, Professor, Graduate School of Public Policy and Graduate School of Law and Politics, University of Tokyo; Director, Institute for Future Initiatives, University of Tokyo

Deputy Directors 

HIROKI NAKATANI, Visiting Professor, Faculty of Medicine, Keio University; Advisor for International Affairs, Ministry of Health, Labour and Welfare (MHLW); Member, WHO Executive Board

OSAMU KUNII, Executive Director and CEO, GHIT Fund (Chair, 100 Days Mission PLUS )

KAYO TAKUMA, Professor, Faculty of Law, Tokyo Metropolitan University (Chair, Global Health Architecture Group)

Japan Working Group 

KEISHI ABE, Senior Fellow, Institute for Policy Studies, National Graduate Institute for Policy Studies

SARAH KRULL ABE, Section Head, Division of Prevention, National Cancer Center Institute for Cancer Control (Scientific Coordinator)

TAKANORI FUJITA, Project Lead of Healthcare Data Project, World Economics Forum Centre for the Forth Industrial Revolution Japan

CHIEKO IKEDA, Director General, Bureau of International Health Cooperation, National Center for Global Health and Medicine (UHC Chair)

MASAKI INABA, Co-Chair, Africa Japan Forum; Chair, Japan CSO Network on Global Health

KAZUAKI JINDAI, Assistant, Graduate School of Medicine, Tohoku University

MIHOKO KASHIWAKURA, Head of Japan, Bill & Melinda Gates Foundation

NAOKI KONDO, Professor, Department of Social Epidemiology, Graduate School of Medicine, Kyoto University

MAKIKO MATSUO, Adjunct Associate Professor, Graduate School of Public Policy, University of Tokyo

YOSHITAKA NISHINO, Research Associate, JCIE/Japan (Assistant Coordinator)

SHUHEI NOMURA, Specially Appointed Associate Professor, Department of Medical Policy and Management, Keio University School of Medicine

HARUKA SAKAMOTO, Associate Professor, Department of Hygiene and Public Health, Tokyo Women’s Medical College

TOMOKO SUZUKI, Chief Program Officer, JCIE/Japan (Chief Coordinator)

AYAKO TAKEMI, WHO Consultant; Project Researcher, Institute for Future Initiatives, University of Tokyo

※We are also requesting cooperation from relevant ministries and agencies

International Advisors

LAV AGARWAL, Additional Secretary, Ministry of Health and Family Welfare, Government of India


SETH BERKLEY, CEO, Gavi, the Vaccine Alliance

JOE CERRELL, Managing Director for Europe, the Middle East, and East Asia (EMEEA), Bill & Melinda Gates Foundation

AWA MARIE COLL-SECK, Minister of State to the President of the Republic of Senegal

THOMAS B. CUENI, Director General, International Federation of Pharmaceutical Manufacturers & Association (IFPMA)

MANDEEP DHALIWAL, Director, HIV, Health and Development Group, Bureau for Policy and Programme Support, United Nations Development Programme (UNDP)

ALAN DONNELLY, Conenor, G20 Health & Development Partnership

PHILIPPE DUNETON, Executive Director, Unitaid

MARK DYBUL, Faculty Co-Director, Center for Global Health and Quality, and Professor, Department of Medicine, Georgetown University Medical Center

VICTOR DZAU, President, National Academy of Medicine (NAM), USA

JEREMY FARRAR, Director, Wellcome Trust

RICHARD HATCHETT, CEO, Coalition for Epidemic Preparedness Innovations (CEPI)

RICHARD HORTON, Editor-in-Chief, the Lancet

ABOUBACAR KAMPO, Director of Health, Programme Group, United Nations Children’s Fund (UNICEF)

NATALIA KANEM, Executive Director, United Nations Population Fund (UNFPA)

ILONA KICKBUSCH, Founder, Global Health Centre at Graduate Institute of International & Development Studies in Geneva

JUSTIN KOONIN, Co-chair, Steering Committee, UHC2030

ROSEMARY MBURU, Executive Director, WACi Health, Kenya

KHUAT THI HAI OANH, Executive Director, Center for Supporting Community Development Initiatives, Vietnam

FRANCIS GERVASE OMASWA, Executive Director, African Centre for Global Health and Social Transformation

SCOTT PENDERGAST, Director, Health Emergencies Strategy, Programmes and Partnerships, World Health Organization (WHO)

PETER PIOT, Special Advisor on COVID-19 to the President, EU Chief Scientific Advisor Epidemics, Cabinet of Ursula Von Der Leyen, President of the European Commission

MICHAEL R. REICH, Takemi Professor of International Health Policy, Emeritus, Harvard T.H. Chan School of Public Health


PETER SANDS, Executive Director, the Global Fund to Fight AIDS, Tuberculosis and Malaria

DIAH SATYANI SAMINARSIH, Founder and CEO, Center for Indonesia’s Strategic Development Initiatives (CISDI); Former Senior Advisor on Gender and Youth to WHO Director General

KENJI SHIBUYA, Research Director, The Tokyo Foundation for Policy Research 

JUAN PABLO URIBE, Global Director for Health Nutrition and Population, World Bank; Director, Global Financing Facility for Women, Children and Adolescents (GFF)

PATRICK VALLANCE, Government Chief Scientific Adviser, UK

WALAIPORN PATCHARANARUMOL, Director, Global Health Division, Ministry of Public Health; Secretary General, IHPP Foundation

NAOKO YAMAMOTO, Appointed Professor, International University of Health and Welfare

ROBERT YATES, Director, Global Health Programme; Executive Director, Centre for Universal Health, Chatham House